5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA

被引：0
|
作者：
Ziemssen, T. [1 ]
Albrecht, H.
Haas, J. [2 ]
Klotz, L. [3 ]
Lang, M.
Lassek, C.
Schmidt, S.
Tackenberg, B. [4 ]
Cornelissen, C. [5 ]
机构：
[1] Carl Gustav Carus Univ Hosp, Dresden, Germany
[2] Jewish Hosp Berlin, Berlin, Germany
[3] Univ Hosp Munster, Munster, Germany
[4] Univ Hosp Giessen & Marburg, Marburg, Germany
[5] Novartis Pharma GmbH, Nurnberg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P745
引用
收藏
页码：372 / 373
页数：2
相关论文
共 50 条
  • [21] 5 years safety experience with fingolimod in real world: results from PANGAEA, a non-interventional study of RRMS patients treated in Germany
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 630 - 630
  • [22] Safety of fingolimod in RRMS patients treated for up to 5 years in real world: interim results from the non-interventional PANGAEA study
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    Effle, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 294 - 295
  • [23] The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
    Ziemssen, Tjalf
    Kern, Raimar
    Cornelissen, Christian
    BMC NEUROLOGY, 2015, 15
  • [24] The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
    Tjalf Ziemssen
    Raimar Kern
    Christian Cornelissen
    BMC Neurology, 15
  • [25] Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
    Tjalf Ziemssen
    Raimar Kern
    Christian Cornelissen
    BMC Neurology, 16
  • [26] Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
    Ziemssen, Tjalf
    Kern, Raimar
    Cornelissen, Christian
    BMC NEUROLOGY, 2016, 16
  • [27] The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI
    Laux, G.
    PHARMACOPSYCHIATRY, 2012, 45 (07) : 284 - 291
  • [28] The fingolimod patient profile 2011 and 2017: a comparison of two non-interventional studies PANGAEA and PANGAEA 2.0
    Cornelissen, C.
    Kern, R.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 595 - 596
  • [29] TOCILIZUMAB ADMINISTERED IN DAILY CLINICAL PRACTICE - FINAL RESULTS OF THE GERMAN NON-INTERVENTIONAL STUDY "ROUTINE"
    Burmester, G. -R.
    von Hinueber, U.
    Richter, C.
    Schwenke, H.
    Guertler, I.
    Kaestner, P.
    Peters, M. A.
    Iking-Konert, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 452 - 452
  • [30] THE ANTIDEPRESSANT EFFICACY OF AGOMELATINE IN DAILY PRACTICE: RESULTS OF THE NON-INTERVENTIONAL STUDY VIVALDI
    Laux, G.
    EUROPEAN PSYCHIATRY, 2011, 26
12345